SE459899B - Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi - Google Patents

Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi

Info

Publication number
SE459899B
SE459899B SE8105561A SE8105561A SE459899B SE 459899 B SE459899 B SE 459899B SE 8105561 A SE8105561 A SE 8105561A SE 8105561 A SE8105561 A SE 8105561A SE 459899 B SE459899 B SE 459899B
Authority
SE
Sweden
Prior art keywords
pak
ketoglutarate
pharmaceutical composition
administration
pyridoxine
Prior art date
Application number
SE8105561A
Other languages
English (en)
Swedish (sv)
Other versions
SE8105561L (sv
Inventor
F Fici
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of SE8105561L publication Critical patent/SE8105561L/
Publication of SE459899B publication Critical patent/SE459899B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8105561A 1980-09-22 1981-09-21 Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi SE459899B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24827/80A IT1141070B (it) 1980-09-22 1980-09-22 Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia

Publications (2)

Publication Number Publication Date
SE8105561L SE8105561L (sv) 1982-03-23
SE459899B true SE459899B (sv) 1989-08-21

Family

ID=11214855

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105561A SE459899B (sv) 1980-09-22 1981-09-21 Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi

Country Status (12)

Country Link
US (1) US4361570A (fr)
JP (1) JPS5782316A (fr)
BE (1) BE890454A (fr)
CA (1) CA1177408A (fr)
CH (1) CH655009A5 (fr)
DE (1) DE3137125A1 (fr)
FR (1) FR2490493B1 (fr)
GB (1) GB2084018A (fr)
IT (1) IT1141070B (fr)
NL (1) NL8104357A (fr)
SE (1) SE459899B (fr)
ZA (1) ZA816242B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (fr) 1999-03-08 2006-09-13 Medicure Inc. Analogues de pyridoxal destines aux troubles provoques par une carence en vitamine b6
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
EP1872797A3 (fr) 1999-08-24 2008-04-02 Medicure International Inc. Traitement des pathologies cardiovasculaires et associées
WO2001064692A1 (fr) 2000-02-29 2001-09-07 Medicure International Inc. Phosphonates et malonates cardioprotecteurs
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (fr) 2004-10-28 2006-05-18 Medicure International Inc. Analogues de pyridoxine a double activite anti-plaquettes et anti-coagulantes
US20090156648A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
WO2009073944A1 (fr) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Utilisation de pyridoxine alpha-hydroxyisocaproate pour réduire l'acidose métabolique et l'accumulation d'ammoniac
US10278327B2 (en) 2014-05-09 2019-05-07 Shakespeare Company, Llc Trimmer head for use with line and blades
WO2020086733A1 (fr) * 2018-10-24 2020-04-30 Ponce De Leon Health Designated Activity Company Compositions de nicotinamide riboside pour prolonger la durée de vie en bonne santé

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6453M (fr) * 1967-06-13 1968-11-12
ES360566A1 (es) * 1968-11-22 1970-10-16 Made Labor Sa Un metodo de obtencion de alfa-cetoglutarato de piridoxina y sus derivados.
US3784553A (en) * 1972-01-17 1974-01-08 Made Labor Sa Pyridoxine alpha-ketoglutarate and its derivatives

Also Published As

Publication number Publication date
FR2490493A1 (fr) 1982-03-26
FR2490493B1 (fr) 1986-03-07
SE8105561L (sv) 1982-03-23
GB2084018A (en) 1982-04-07
IT1141070B (it) 1986-10-01
DE3137125C2 (fr) 1989-04-06
ZA816242B (en) 1982-08-25
CH655009A5 (it) 1986-03-27
JPS5782316A (en) 1982-05-22
CA1177408A (fr) 1984-11-06
NL8104357A (nl) 1982-04-16
US4361570A (en) 1982-11-30
IT8024827A0 (it) 1980-09-22
DE3137125A1 (de) 1982-04-01
BE890454A (fr) 1982-01-18

Similar Documents

Publication Publication Date Title
SE459899B (sv) Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi
US10485774B2 (en) Enterically coated cysteamine, cystamine and derivatives thereof
CN101897970A (zh) 用于治疗糖尿病的组合物和方法
US20080249168A1 (en) Pharmaceutical composition for gout
Slonim et al. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy
HILLMAN Tocopherol excess in man: Creatinuria associated with prolonged ingestion
ARTHUR MIRSKY et al. The hypoglycemic action of metabolic derivatives of L-tryptophan by mouth
McDaniel et al. Tryptophan-niacin metabolism in alloxan diabetic rats
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
Sackner et al. Severe hypoglycemia after the ingestion of a sulfonylurea compound
JPH03135918A (ja) 免疫賦活剤
CN116761601A (zh) 依达拉奉口服给药用医药组合物及其给药方法
Frost The relation of nutritional deficiencies to graying
EP0137514B1 (fr) Dérivés et compositions utiles dans la prévention et le traitement de l'obésité
Kurlan Dietary therapy for motor fluctuations in Parkinson's disease
JP2001048794A (ja) 桑の葉由来粉末およびカキ由来粉末の混合物を含むｎｉｄｄｍ治療用の医薬組成物および健康食品
JPS6051110A (ja) 家畜のケト−ジス治療剤
Lloyd-Still et al. Intravenous hyperalimentation in pediatrics
WO2022061962A1 (fr) Méthode pour intervenir efficacement sur le diabète à l'aide d'un inhibiteur ou d'un antagoniste du transporteur d'acides aminés de type l
CN1913879B (zh) 用于治疗糖尿病的组合物和制药用途
Seino et al. Effect of dietary environment on the development of impaired glucose tolerance and pancreatic hormone secretion in neonatal streptozocin-treated (NSZ) rats
Nabih et al. Structure and activity of thiazole‐type schistosomicidal agents
JPH0549646B2 (fr)
JP2005015417A (ja) 抗疲労組成物
US5238960A (en) Use of acetic acid for regulating blood sugar levels

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8105561-8

Effective date: 19920408

Format of ref document f/p: F